» Articles » PMID: 3580264

Photodynamic Therapy with Phthalocyanine Sensitisation: Quantitative Studies in a Transplantable Rat Fibrosarcoma

Overview
Journal Br J Cancer
Specialty Oncology
Date 1987 Apr 1
PMID 3580264
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Photodynamic therapy (PDT) is a promising approach to the local destruction of malignant tumours, but little work has been done to determine which factors control the extent of tissue necrosis produced. Using a new photosensitiser, a sulphonated aluminium phthalocyanine (AlSPc) and light from an argon ion pumped dye laser at 675 nm, we quantified the effects of interstitial PDT in a transplantable fibrosarcoma in rats. At 100mW laser power, thermal effects were comparable to those of PDT, so subsequent studies were carried out at 50 mW, where thermal effects were minimal. The depth of PDT necrosis increased with the logarithm of the applied energy. Tissue concentration of AlSPc was measured by alkali extraction and at all times after sensitisation, correlated well with the necrosis produced with a given light dose. Peak tumour concentration of AlSPc occurred 24-48 h after sensitisation compared with a peak at 3 h in muscle. The peak ratio tumour:muscle was 2:1 at 24 h. Apart from a different time interval to reach the peak sensitiser concentration, the extent of tumour damage varied with the light and sensitiser parameters in a similar way to that found in normal liver, although the optical penetration depth was greater in the tumour (2.5 mm vs. 1.8 mm). At doses of AlSPc below 1 mg kg-1 the diameter of necrosis increased with the logarithm of the dose of sensitiser, and doubling the dose from 0.25 to 0.5 mg kg-1 increased the depth of necrosis by 50%. However, at higher doses, the changes were smaller and increasing the dose from 2.5 to 5 mg kg-1 only increased the necrosis by 10% for the same light dose. In all dose ranges, a given percentage increase in the tissue concentration of AlSPc gave a much smaller percentage increase in the extent of necrosis for the same light dose, suggesting that selectivity of necrosis between tumour and normal tissue is likely to be much less than the selectivity of retention of the photosensitiser. From these results, the extent of PDT necrosis in this fibrosarcoma is as predictable as it is in normal liver if the light dose, tissue concentration of AlSPc and optical penetration depth of the tissue are known. Further studies are now required on different tumour models to establish how tumours respond compared with adjacent normal tissue when the tumour is growing in its organ of origin rather than the non-physiological situation using a transplantable tumour as in this study.

Citing Articles

Like a bolt from the blue: phthalocyanines in biomedical optics.

Sekkat N, van den Bergh H, Nyokong T, Lange N Molecules. 2011; 17(1):98-144.

PMID: 22198535 PMC: 6269082. DOI: 10.3390/molecules17010098.


Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas.

Smith S, Bedwell J, MacRobert A, Griffiths M, Bown S, Hetzel M Thorax. 1993; 48(5):474-80.

PMID: 8322231 PMC: 464496. DOI: 10.1136/thx.48.5.474.


Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.

Barr H, Tralau C, MacRobert A, Krasner N, Boulos P, Clark C Br J Cancer. 1987; 56(2):111-8.

PMID: 3663462 PMC: 2002142. DOI: 10.1038/bjc.1987.166.


Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice.

Reddi E, Lo Castro G, Biolo R, Jori G Br J Cancer. 1987; 56(5):597-600.

PMID: 3426922 PMC: 2001878. DOI: 10.1038/bjc.1987.247.


Photodynamic therapy for colorectal disease.

Barr H, Bown S, Krasner N, Boulos P Int J Colorectal Dis. 1989; 4(1):15-9.

PMID: 2651542 DOI: 10.1007/BF01648544.


References
1.
GREGORIE Jr H, Horger E, Ward J, Green J, Richards T, ROBERTSON Jr H . Hematoporphyrin-derivative fluorescence in malignant neoplasms. Ann Surg. 1968; 167(6):820-8. PMC: 1387148. DOI: 10.1097/00000658-196806000-00002. View

2.
Weishaupt K, Gomer C, Dougherty T . Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976; 36(7 PT 1):2326-9. View

3.
Gomer C, Dougherty T . Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 1979; 39(1):146-51. View

4.
Bugelski P, Porter C, Dougherty T . Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res. 1981; 41(11 Pt 1):4606-12. View

5.
Profio A, Doiron D . Dosimetry considerations in phototherapy. Med Phys. 1981; 8(2):190-6. DOI: 10.1118/1.594932. View